inflammatory breast carcinoma (Cancer)
Information
- Disease name
- inflammatory breast carcinoma
- Disease ID
- DOID:6263
- Description
- "A breast adenocarcinoma that is characterized by the clinical appearance of inflammation, with edema and redness of the breast due to pathologic plugging of the dermal lymphatics of the breast with tumor emboli." [url:https\://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852616/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01730833 | Active, not recruiting | Phase 2 | Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer | July 17, 2013 | December 31, 2024 |
| NCT02876107 | Active, not recruiting | Phase 2 | Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer | October 6, 2016 | October 31, 2025 |
| NCT00070252 | Completed | Phase 1/Phase 2 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | September 2003 | June 2010 |
| NCT01894451 | Completed | Early Phase 1 | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy | June 2015 | March 17, 2017 |
| NCT02227082 | Completed | Phase 1 | Olaparib and Radiotherapy in Inoperable Breast Cancer | October 21, 2013 | August 2020 |
| NCT03872388 | Completed | Phase 2 | Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy | January 14, 2019 | October 19, 2023 |
| NCT00477100 | Recruiting | Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer | April 17, 2007 | April 30, 2030 | |
| NCT01755130 | Terminated | N/A | Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer | May 13, 2014 | June 2, 2021 |
| NCT01641406 | Unknown status | Phase 2 | "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" | March 2011 | March 2013 |
| NCT01038258 | Unknown status | N/A | Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy | July 2007 | April 2013 |
- Disase is a (Disease Ontology)
- DOID:3458
- Cross Reference ID (Disease Ontology)
- MESH:D058922
- Cross Reference ID (Disease Ontology)
- NCI:C4001
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:254840009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0278601
- Exact Synonym (Disease Ontology)
- Inflammatory carcinoma of breast
- Exact Synonym (Disease Ontology)
- Mastitis carcinomatosa